R. Street Institute Research Fellow Chelsea Boyd addresses the “pause” on distributing the Johnson & Johnson vaccine for COVID-19. Boyd explains why governments and medical professionals pause the usage of a pharmaceutical even if there’s no direct evidence the drug is harmful. She also addresses some of the concerns mentioned by those who choose not to get the vaccine.